The broker, which has a target price of 235p, said the company’s core market of Teleradiology is capacity constrained and seeing accelerating demand.
Medica’s strategy, therefore, of building an international network of teleradiologists, coupled with an efficient technology platform, means it is ideally placed to tap this demand and hit its growth targets.
Liberum expects 14% sales growth and 22% earnings growth in the medium term, which isn’t reflected in the forward earnings multiple of 18 times.
Buy is its investment view
Shares rose 1.2% to 167p.